Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report)’s stock price was down 2.4% on Monday after an insider sold shares in the company. The company traded as low as $36.92 and last traded at $36.97. Approximately 253,159 shares traded hands during mid-day trading, a decline of 55% from the average daily volume of 559,643 shares. The […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) SVP Lauren Bullaro Riker sold 6,366 shares of the firm’s stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $38.42, for a total value of $244,581.72. Following the completion of the sale, the senior vice president now owns 22,687 shares […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) CEO David M. Stack sold 5,058 shares of the company’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $38.99, for a total transaction of $197,211.42. Following the transaction, the chief executive officer now owns 159,107 shares of the company’s […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) COO Daryl Gaugler sold 1,047 shares of the business’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $37.87, for a total transaction of $39,649.89. Following the completion of the transaction, the chief operating officer now owns 21,539 shares in […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) Director Paul J. Hastings sold 580 shares of the company’s stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $38.34, for a total transaction of $22,237.20. Following the sale, the director now owns 6,599 shares in the company, […]